We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra Investments. In this article, we will ...
We recently published a list of the 12 Best Long-Term Growth Stocks to Buy Now. In this article, we are going to take a look ...
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...
Not all growth stocks worth buying these days focus on the artificial intelligence field. There are many exciting ones in ...
Released on Friday, February 7, the January jobs report showed resilience in the labor market with higher-than-expected wage ...
8hon MSN
Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit these popular categories the hardest.
1d
Hosted on MSNLLY Rises More Than 4% in a Week: How to Play the StockEli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...
4d
24/7 Wall St. on MSNMy 3 Top Picks for Stocks That Could Double Over the Next 3 YearsFinding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of ...
Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...
2d
MarketBeat on MSNGLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss TrendsDetailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...
Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results